Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Early identification of lupus through skin signs and blood tests is crucial in India.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Autophagy is important for human hair growth and health.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

A new mouse model effectively mimics vitiligo for research and drug testing.

Lithium can cause skin discoloration even at normal levels, so monitor for signs of intoxication.

Hair regrowth in alopecia universalis may be possible by altering immune cells.